EPAS1: A Non-Coding RNA Molecule with A Variety of Roles in Cellular Processes

Target Name: EPAS1

NCBI ID: G2034

EPAS1

EPAS1: A Non-Coding RNA Molecule with A Variety of Roles in Cellular Processes

EPAS1 (MOP2), also known as SIRT1, is a non-coding RNA molecule that has been shown to have a variety of roles in various cellular processes. One of its functions is to regulate the balance of protein synthesis and degradation in the cell, which is important for maintaining cellular homeostasis and growth.

Recent studies have also suggested that EPAS1 plays a role in diseases such as cancer, neurodegenerative diseases, and aging. In addition, its potential as a drug target has led to a great deal of interest and research in the field of pharmacology.

The mechanism of action of EPAS1 is not well understood, but it is known that it can interact with a variety of protein targets. This interaction has led to the proposal that EPAS1 functions as a negative regulator of protein synthesis, by inhibiting the activity of translation factors that are involved in protein synthesis.

EPAS1 has also been shown to play a role in the regulation of cellular stress responses. It has been shown to interact with stress-responsive transcription factors, such as ATF-2, and to regulate the expression of genes involved in stress response. This suggests that EPAS1 may be involved in the regulation of cellular stress responses, and that it may be a potential drug target for diseases associated with stress.

In addition to its role in stress responses, EPAS1 has also been shown to be involved in the regulation of cell cycle progression. It has been shown to interact with the protein kinase A-Tyr kinase, which is involved in the regulation of cell cycle progression. This suggests that EPAS1 may be involved in the regulation of cell cycle progression, and that it may be a potential drug target for diseases associated with cell cycle dysfunction.

The potential drug targets for EPAS1 are vast, and include a wide range of protein targets that are involved in various cellular processes. Some potential targets include the heat shock protein HSP70, which is involved in the regulation of protein synthesis and degradation, and the stress-responsive transcription factor ATF-2, which is involved in the regulation of stress responses.

In addition to its potential as a drug target, EPAS1 has also been shown to have a variety of potential therapeutic applications. For example, it has been shown to be involved in the regulation of stem cell self-renewal, and to play a role in the development of cancer. It has also been shown to be involved in the regulation of the onset of neurodegenerative diseases, and to be involved in the regulation of aging.

In conclusion, EPAS1 (MOP2) is a non-coding RNA molecule that has a variety of roles in cellular processes, including the regulation of protein synthesis and degradation, stress responses, and cell cycle progression. Its potential as a drug target has generated a great deal of interest and research in the field of pharmacology, and its potential therapeutic applications are vast and varied. Further studies are needed to fully understand the mechanism of action of EPAS1 and its potential as a drug target.

Protein Name: Endothelial PAS Domain Protein 1

Functions: Transcription factor involved in the induction of oxygen regulated genes. Heterodimerizes with ARNT; heterodimer binds to core DNA sequence 5'-TACGTG-3' within the hypoxia response element (HRE) of target gene promoters (By similarity). Regulates the vascular endothelial growth factor (VEGF) expression and seems to be implicated in the development of blood vessels and the tubular system of lung. May also play a role in the formation of the endothelium that gives rise to the blood brain barrier. Potent activator of the Tie-2 tyrosine kinase expression. Activation requires recruitment of transcriptional coactivators such as CREBBP and probably EP300. Interaction with redox regulatory protein APEX1 seems to activate CTAD (By similarity)

The "EPAS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about EPAS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets